Shares of Kalbe Farma (KLBF), the largest pharmaceutical group in Indonesia, ended higher by 3.128% to Rp1,135 last Thursday (Mar 27) as investors anticipated improved financials of the company. It indeed reported an unprecedented 17% growth in net profit to Rp3.24 trillion last year on improved operational margins and strong balance sheet. To subscribe please click here
